DALLAS, November 28, 2014
/PRNewswire/ --
ReportsnReports.com adds Global Anti-Obesity Drugs Market
2015-2019 research report of 78 pages to the fast growing
pharmaceuticals industry intelligence and data collection of its
library. According to this research, the global anti-obesity drugs
market is set to grow at a CAGR of 39.45% over the period
2014-2019. Complete research is available at
http://www.reportsnreports.com/reports/318547-global-anti-obesity-drugs-market-2015-2019.html
.
For the anti-obesity drugs market, growing rates of obesity
worldwide are offering huge opportunities for drug manufacturing
companies to develop and manufacture highly effective drugs.
Vendors are expected to gear up for intense competition in the
worldwide anti-obesity drugs industry. New pipeline drugs developed
by vendors should display efficacy and safety profiles that surpass
options currently on the market. The landscape is vast, with
competitors ranging from Arena Pharmaceuticals and Orexigen
Therapeutics to big pharmaceutical companies, gearing up to make
better, more effective anti-obesity drugs with fewer side effects.
Anti-obesity drugs currently available on the market come with a
list of troubling side effects. Any product offerings that are safe
for long-term use will likely have a positive impact on market
growth through to 2019.
The Global Anti-obesity Drugs market is divided into two
segments: Peripherally Acting Anti-obesity Drugs and Centrally
Acting Anti-obesity Drugs. This report covers the present scenario
and the growth prospects of the Global Anti-obesity Drugs market
for the period 2014-2019. To calculate the market size, the report
considers the revenue generated from the sales of FDA approved
drugs and OTC medications used in the treatment of obesity that are
available in the market.
Anti-Obesity drug companies like Arena Pharmaceuticals,
F. Hoffmann-La Roche,
GlaxoSmithKline, Orexigen Therapeutics, Vivus, Amylin, Alizyme,
Boehringer Ingelheim, Eisai, Merck, Norgine, Novo Nordisk, Pfizer,
Rhythm Pharmaceuticals, Shionogi USA, Takeda Pharmaceutical and Zafgan are
discussed in this research available for purchase at
http://www.reportsnreports.com/Purchase.aspx?name=318547
.
The Global Anti-obesity Drugs Market 2015-2019 report has been
prepared based on an in-depth market analysis with inputs from
industry experts. The report covers the Americas, the APAC and EMEA
regions; it also covers the Global Anti-obesity Drugs market
landscape and its growth prospects in the coming years. The report
also includes a discussion of the key vendors operating in this
market. Key questions on the anti-obesity drugs sector like what
will the market size be in 2018 and what will the growth rate be?
What are the key market trends? What is driving this market? What
are the challenges to market growth? Who are the key vendors in
this market space? What are the market opportunities and threats
faced by the key vendors? What are the strengths and weaknesses of
the key vendors? are answered through this research.
20 data exhibits provided in this worldwide anti-obesity drugs
market research include:
Market Research Methodology
Global Anti-obesity Drugs Market 2013-2018 (US$ million)
US Prevalence of Adult Overweight and Obesity (NHANES
2011-2012)
US Prevalence of Childhood Overweight and Obesity (NHANES
2011-2012)
Types of Obesity
Causes of Obesity
Global Anti-obesity Drugs Market Segmentation by Drug Class
Global Anti-obesity Drugs Market by Geographical Segmentation
2014
Arena Pharmaceuticals: Geographical Segmentation
F. Hoffmann-La Roche: Business
Segmentation by Revenue 2013
F. Hoffmann-La Roche: Business
Segmentation by Revenue 2012 and 2013
F. Hoffmann-La Roche: Revenue of
Pharmaceuticals Division by Geography 2013
F. Hoffmann-La Roche: Revenue of
Diagnostics Division by Geography 2013
GlaxoSmithKline: Business Segmentation 2013
GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013
(US$ billion)
GlaxoSmithKline: Sales by Geography 2013
GlaxoSmithKline: Pipeline Products 2013
Vivus: Business Segmentation by Revenue 2013
Vivus: Business Segmentation by Revenue 2012 and 2013 (US$
million)
Vivus: Geographical Segmentation by Revenue 2013
On a relevant topic, the Weight Loss/Obesity Management
Market - [Meal Replacements, Slimming
Centers, Nutrition & Psychological Consultancy, Treadmill,
Ellipticals, Strength Training, Gastric Bypass, Intragastric
Balloon System, Stomaphyx] - Global Forecasts To 2017 research
report says worldwide weight loss/obesity management market is
expected to reach $361 billion by
2017. Low calorie beverages (carbonated and non-carbonated), and
slimmer waters/natural mineral salt drinks showcase vast
opportunities for key players in this market. Herbal/green market
is also growing at a very fast pace in Asian countries, especially
in China. The Asian market,
especially India and China, is expected to witness a boost in
demand for weight loss products, and is poised to register maximum
growth over the next five years, owing to the rising obesity rates
and related health problems. Atkins Nutritionals, Inc. (U.S.),
Weight Watchers International, Inc. (U.S.), NutriSystem, Inc.
(U.S.), Herbalife International, Inc. (U.S.), The Coca Cola Company
(U.S.), and PepsiCo, Inc. (U.S.) are the leading global players in
the weight loss diet market, while the weight loss services market
is lead by Equinox, Inc. (U.S.), Life Time Fitness, Inc. (U.S.),
Golds Gym International, Inc. (U.S.), Weight Watchers
International, Inc. (U.S.), and eDiets.com (U.S.) Brunswick
Corporation (U.S.), Fitness First (U.K.), Precor, Inc. (U.S.), ICON
Health &; Fitness, Inc. (U.S.), LifeCORE Fitness, Inc. (U.S.),
and Johnson Health Tech. Co., Ltd (Taiwan) are leading players in the weight loss
fitness equipment market. Ethicon Endo-surgery, Inc. (U.S.),
Cynosure, Inc. (U.S.), and Allergan, Inc. (U.S.) are eminent
players in the global weight loss surgical equipment market.
Comprehensive table of contents and more on this research is
available at
http://www.reportsnreports.com/reports/247344-weight-loss-obesity-management-market-meal-replacements-slimming-centers-nutrition-psychological-consultancy-treadmill-ellipticals-strength-training-gastric-bypass-intragastric-balloon-system-stomaphyx-global-forecasts-to-2017.html
.
Explore more reports by Infiniti Research Ltd at
http://www.reportsnreports.com/publisher/infiniti-research-limited/
and by MarketsandMarkets at
http://www.reportsnreports.com/publisher/marketsandmarkets/ .
About Us:
ReportsnReports.com is an online market research reports library
of 500,000+ in-depth studies of over 5000 micro markets. Not
limited to any one industry, ReportsnReports.com offers research
studies on agriculture, energy and power, chemicals, environment,
medical devices, healthcare, food and beverages, water, advanced
materials and much more.
Contact:
Ritesh Tiwari
TX, Dallas North - Dominion
Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Tel: +1-888-391-5441
sales@reportsandreports.com
Connect With Us on:
Facebook: https:
//www.facebook.com/pages/ReportsnReports/191441427571689
LinkedIn:
www.linkedin.com/company/reportsnreports
Twitter: https: //twitter.com/marketsreports
G+ / Google
Plus: https://plus.google.com/111656568937629536321/posts
Pinterest:
www.pinterest.com/comeonseo/reportsnreports/
RSS/Feeds: http:
//www.reportsnreports.com/feed/l-latestreports.xml
SOURCE ReportsnReports